Hepion Pharmaceuticals, Inc.
Filings
| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2026-08-058/5/26 | New | $3,055,000 | $3,055,000 | Equity Only | 06b | SEC linkSEC |
| 2026-04-224/22/26 | New | $700,000 | $700,000 | Equity Only | 06b | SEC linkSEC |
| 2024-07-247/24/24 | New | $2,900,000 | $2,900,000 | Equity and Debt | 06b | SEC linkSEC |
| 2023-10-0310/3/23 | New | $5,000,004 | $5,000,004 | Equity Only | 06b | SEC linkSEC |
| 2022-11-1511/15/22 | New | $20,000,000 | $20,000,000 | Equity Only | 06b | SEC linkSEC |
| 2019-03-273/27/19 | New | $1,250,000 | $1,250,000 | Equity and Debt | 06b | SEC linkSEC |
| 2014-10-2310/23/14 | New | $9,000,000 | $9,000,000 | Equity Only | 06b | SEC linkSEC |
| 2014-08-228/22/14 | New | $4,742,648 | $4,742,648 | Equity Only | 06b | SEC linkSEC |
| 2014-02-142/14/14 | New | $3,225,000 | $3,225,000 | Equity Only | 06b | SEC linkSEC |
Directors and Executives (Current and Past)
| Name | Role |
|---|---|
| Thomas Adams | Director |
| Sireesh Appajosyula | Director |
| Timothy Block | Director |
| John P. Brancaccio | Director |
| John Cavan | Executive |
| Bernard F. Denoyer | Director, Executive |
| Dania Fisher | Director |
| Robert Foster | Director, Executive |
| Todd Hobbs | Executive |
| Bill Hornung | Executive |
| Gary S. Jacob | Director |
| Gary S. Jacobs | Director |
| Kaouthar Lbiati | Director |
| Arnold Lippa | Director |
| Vincent Lo Priore | Director, Executive |
| Chase Lo Priore | Director |
| Christopher Mc Guigan | Director |
| Michael Purcell | Director |
| Anand Reddi | Director |
| James Sapirstein | Director, Executive |
| Gary Stetz | Director, Executive |
| Gary S. Stetz, Ii | Director |
| Petrus Wijngaard | Director |
Industry: Biotechnology (See others in industry)
Address:
34 Shrewsbury Ave. Suite 1 D
Red Bank, NJ, 07701
Phone: (732) 902-4000
Red Bank, NJ, 07701
Phone: (732) 902-4000